UPDATED May 02, 2024
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2330 | NT$776.00 | -0.8% | 55.2% | NT$20.0t | NT$912.98 | PE23.5x | E16.1% | 1.8% | Semiconductors | ||
AZN | UK£121.56 | 1.1% | 2.6% | UK£188.4b | UK£131.66 | PE37.3x | E16.5% | 2.0% | Pharmaceuticals & Biotech | ||
QCOM | US$180.10 | 8.7% | 65.6% | US$201.0b | US$183.91 | PE23.8x | E9.2% | 1.8% | Semiconductors | ||
NOVN | CHF88.87 | -1.3% | -4.1% | CHF181.3b | CHF99.68 | PE21.9x | E10.1% | 3.7% | Pharmaceuticals & Biotech | ||
ROG | CHF214.10 | -2.1% | -24.1% | CHF172.8b | CHF279.39 | PE14.8x | E8.6% | 4.5% | Pharmaceuticals & Biotech | ||
SAF | €202.80 | -2.3% | 47.7% | €83.9b | €210.37 | PE24.4x | E7.1% | 1.1% | Capital Goods | ||
ZURN | CHF440.70 | -0.4% | 3.6% | CHF63.5b | CHF462.38 | PE16x | E8.9% | 5.8% | Insurance | ||
SLB | US$47.58 | -3.8% | 5.6% | US$67.4b | US$66.67 | PE15.7x | E15.4% | 2.3% | Energy | ||
NTES | US$98.95 | 5.1% | 11.4% | US$60.6b | US$133.77 | PE15.7x | E7.9% | 2.6% | Media | ||
300760 | CN¥304.59 | 5.5% | -3.1% | CN¥368.4b | CN¥394.25 | PE30.3x | E15.0% | 1.9% | Healthcare | ||
2454 | NT$1,045.00 | 4.0% | 54.8% | NT$1.6t | NT$1,199.10 | PE21.6x | E13.3% | 5.8% | Semiconductors | ||
BBRI | Rp4,760.00 | -1.4% | -8.9% | Rp717.8t | Rp6,258.00 | PB2.4x | E9.6% | 6.7% | Banks | ||
BMRI | Rp6,325.00 | -6.3% | 22.2% | Rp590.3t | Rp7,583.63 | PB2.5x | E9.7% | 5.6% | Banks | ||
HAL | ₹3,920.20 | -1.6% | 166.3% | ₹2.6t | ₹3,091.36 | PE42.7x | E10.0% | 0.8% | Capital Goods | ||
EVO | kr1,206.50 | -3.1% | -6.5% | kr254.6b | kr1,489.06 | PE20.1x | E12.4% | 2.6% | Consumer Services | ||
300274 | CN¥103.35 | 4.1% | -3.9% | CN¥151.8b | CN¥130.67 | PE15.1x | E11.2% | 0.9% | Capital Goods | ||
KCHOL | ₺235.00 | 10.1% | 207.4% | ₺595.9b | ₺215.07 | PE8.3x | E26.5% | 3.4% | Capital Goods | ||
SOON | CHF259.90 | 3.3% | -8.2% | CHF15.5b | CHF270.88 | PE25.8x | E10.7% | 1.8% | Healthcare | ||
ALL | AU$39.92 | -0.7% | 6.3% | AU$24.7b | AU$47.49 | PE17.4x | E5.1% | 1.7% | Consumer Services | ||
JMT | €19.36 | 3.9% | -15.2% | €12.2b | €23.51 | PE17.1x | E8.6% | 3.4% | Consumer Retailing | ||
300122 | CN¥35.10 | 0.8% | -32.9% | CN¥84.0b | CN¥62.47 | PE11.2x | E22.8% | 2.3% | Pharmaceuticals & Biotech | ||
600845 | CN¥41.03 | 3.2% | -7.7% | CN¥83.2b | CN¥49.57 | PE37.3x | E21.4% | 2.4% | Software | ||
DOX | US$83.64 | -1.6% | -6.7% | US$9.7b | US$104.90 | PE17.4x | E15.8% | 2.3% | Software | ||
2648 | CN¥19.28 | 5.1% | 32.7% | CN¥64.8b | CN¥21.45 | PE12.7x | E19.5% | 2.1% | Materials |